Influenza A/B Rapid Test Kits Suppliers & Bulk Manufacturers
Available Forms: Lateral flow immunoassay/Dipstick or strip formats
Available Strengths: high accuracy suitable for point-of-care diagnosis
Reference Brands: Quidel QuickVue Influenza, BD Veritor, Sofia Influenza A+B, Abbott BinaxNOW(US)
Category:
Rapid Test Kits
Influenza A/B rapid test kits detect viral antigens using immunoassay technology, providing results within 10-15 minutes. They enable quick diagnosis of flu infections, supporting timely treatment, reducing transmission, and improving patient outcomes. They are vital for effective flu management, especially during seasonal outbreaks.
Influenza A/B Rapid Test Kits is available in Lateral flow immunoassay/Dipstick or strip formats
and strengths such as high accuracy suitable for point-of-care diagnosis.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Influenza A/B Rapid Test Kits is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Influenza A/B Rapid Test Kits can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Influenza A/B rapid test kits are approved in both the US and EU, supported by dossiers demonstrating high sensitivity, specificity, and manufacturing quality in accordance with GMP and IVDR standards. In the US, FDA clearance ensures performance and safety; in the EU, CE marking certifies compliance with in vitro diagnostic regulations. These kits undergo extensive validation, clinical performance testing, stability assessments, and quality audits. Proper documentation includes safety profiles, performance data, and certification details. For comprehensive licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees reliable, rapid influenza detection, enabling timely treatment and infection control across global healthcare settings.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing